Several studies have looked retrospectively at tumor markers, including alpha-fetoprotein (AFP), carcinoembryonic antigen (CEA), cancer antigen 19-9 (CA 19-9), as well as imaging and failed to find any unique characteristic features in cHCC-ICC patients [10,11,12]. This evidence concerns the gene CEACAM5 and neoplasm.